JD Health International, Inc. (HK:6618) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
JD Health International, Inc. reported a significant rise in revenue and profits for the third quarter of 2024, with revenue increasing by 14.8% and profit surging by 212.2% compared to the same period in 2023. The company expanded its pharmaceutical offerings and online medical services, enhancing its service model by integrating online consultations and at-home testing services in major cities like Beijing and Shanghai. JD Health also introduced online payment services through medical insurance accounts, further solidifying its position in the healthcare market.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.